Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing 2024-11-12 21:15
Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne 2024-11-12 19:30
Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks 2024-11-12 19:00
Tsingke Successfully Showcases Innovations at BIO-Europe 2024 2024-11-12 17:07
World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R) 2024-11-12 14:00
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd. 2024-11-11 21:45
Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future 2024-11-11 20:56
Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes 2024-11-11 20:47
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe 2024-11-11 20:30
ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults 2024-11-11 19:36
TB Alliance Joins Indonesia's High-Level Meeting on TB 2024-11-11 10:30
Late-Breaking Abstract! Alphamab Oncology Presented the Latest Clinical Data of Anti-HER2 bispecific ADC Subcutaneous Co-formulation JSKN033 at SITC 2024 2024-11-11 10:04
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozyme™ Technology 2024-11-11 08:07
Henlius and SVAX Forge Strategic Partnership in the MENAT Market 2024-11-09 00:35
Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference 2024-11-08 22:00
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-11-08 18:01
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease 2024-11-08 17:45
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC 2024-11-08 10:40
1 2 3 4 5 412